Argos Therapeutics Inc. (Nasdaq: ARGS) widened fourth quarter losses to 84 cents per share from 83 cents per share a year earlier as revenue fell but the stock price climbed $1.10 to close at $7.89.
Argos Therapeutics widens losses
March 30, 2016 at 16:34 PM EDT
